Digestive enzymes are essential proteins that help break down food into smaller molecules during digestion so the body can absorb nutrients. Growing cases of digestive issues like indigestion, heartburn, flatulence and bloating has fueled the demand for digestive enzymes. With hectic lifestyles and processed food consumption on the rise, gut health has become a major concern pushing people to take digestive enzyme supplements for proper nutrient absorption.

The global Digestive Enzyme Market is estimated to be valued at US$ 569 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Rising Digestive Issues
The key opportunity for the digestive enzyme market lies in the rising prevalence of digestive issues owing to irregular eating habits, antibiotic usage and sedentary lifestyles. With growing economic prosperity, consumption of convenience and junk foods that are low in fiber and high in fat have become commonplace. Such an unhealthy diet pattern disrupts the balance of gut microbiota and impairs digestion. As digestive issues negatively impact quality of life, people are increasingly turning to dietary supplements like digestive enzymes to boost digestive health. The digestive enzyme market is therefore poised to experience significant growth driven by growing need to address digestive problems.

Porter's Analysis
Threat of new entrants: The digestive enzyme market has moderate barrier for new companies to enter as it requires high R&D investment and strict regulatory approvals. However, small players can enter by targeting specific customer segments.

Bargaining power of buyers: The bargaining power of buyers is moderate as the digestive enzyme products have substitutes and buyers can switch between brands based on price and quality.

Bargaining power of suppliers: The bargaining power of suppliers is low as there are many raw material suppliers for digestive enzymes and buyers can source from alternative suppliers.

Threat of new substitutes: The threat of new substitutes is moderate as probiotic supplements and gut health products offer alternatives but lack focused digestive support.

Competitive rivalry: The competitive rivalry is high due to presence of many global and regional players offering differentiated products.

SWOT Analysis

Strength: Digestive enzyme products offer natural solution to improve digestion without medical intervention. Wide product portfolio covers needs of customers with specific dietary requirement.

Weakness: Customers have low awareness about importance and benefits of digestive enzymes. High prices compared to generics limit mass adoption.

Opportunity: Rising health consciousness is driving demand for preventive healthcare. Growth in food intolerance cases presents opportunity to spread awareness about role of digestive enzymes.

Threats: Stringent regulations for new product approvals can limit inorganic growth opportunities. Shift to herbal alternatives pose competition.

Key Takeaways

The global digestive enzyme market is expected to witness high growth led by rising gut health awareness among consumers. The global Digestive Enzyme Market is estimated to be valued at US$ 569 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

North America dominates the market currently due to proactive preventive healthcare approach. The region accounts for over 40% of global digestive enzyme sales in 2023 led by US. Europe is the second largest market owing to increasing incidence of digestive disorders among aging population in countries like Germany, UK and Italy.

Key players operating in the digestive enzyme market are National Enzyme Company, Garden of Life LLC , Country Life LLC, Rainbow Life Nutritional System Inc., Food State Inc., Matsun Nutrition , Metagenics, Inc., TwinLab Corporation, Abbott Nutrition , Amway Corporation, Klaire Labs, Zenwise Health LLC, Integrative Therapeutics, LLC , Douglas Labs , Enzymedica Inc., Thorne Research Inc., Pure Encapsulations, LLC, Ortho Molecular Products Inc., Allergy Research Group, Biotics Research Corp. The companies are focused on launching new products targeting specific customer segments like vegans, lactose intolerant and gluten sensitivity to gain market share.A